Biocompatibles to evaluate Bead Block for uterine fibroids
This article was originally published in Clinica
Executive Summary
UK company Biocompatibles International has told Clinica it is soon to begin clinical evaluation of its Bead Block embolisation therapy for treating uterine fibroids. The Farnham, Surrey-based company said a non-US clinical trials programme is scheduled to commence later this year.